Clinical trial
Experiences of Mothers Considering Breastfeeding Cessation: Decision-Making Process, Exploration of Methods, and Support Needs
NCT07890142 is registered in ClinicalTrials.gov with Istanbul University - Cerrahpasa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Experiences of Mothers Considering Breastfeeding Cessation: Decision-Making Process, Exploration of Methods, and Support Needs
- Lead sponsor
- Istanbul University - Cerrahpasa
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 30, 2026
- Completion date
- March 31, 2027
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breastfeeding cessation
Arms
As registered; 1 arm.
-
Mothers Considering Breastfeeding Cessation
Mothers aged 18 years or older who are currently breastfeeding a child aged at least 6 months and are actively considering or planning breastfeeding cessation. Participants will be recruited using purposive sampling, with an emphasis on maximum variation. Data will be collected through individual semi-structured interviews. No intervention will be assigned by the researchers. Kopyala
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Experiences of Mothers Considering Breastfeeding Cessation
Mothers' experiences regarding breastfeeding cessation will be explored through individual semi-structured interviews. The interviews will examine decision-making processes, information sources, exploration of cessation methods, uncertainties, anticipated or experienced difficulties, and perceived support needs. Interview transcripts will be analyzed using thematic analysis to identify themes and subthemes reflecting participants' experiences.
Lead sponsor's other trials
Istanbul University - Cerrahpasa, most recent start first.
+695 more trials